Background: Diagnoses of chlamydia and gonorrhoea have increased steadily in Australia
Background
Sexually transmissible infections (STIs) are an important public health issue. Left untreated, STIs can cause reproductive morbidity (1) (2) (3) and increase the risk of HIV transmission. (4, 5) In Australia diagnoses of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) have increased steadily in the past decade.(6) High rates of CT and NG are seen in gay, bisexual and other men who have sex with men (GBM) and Aboriginal and/or Torres Strait Islander peoples (hereafter referred to as 'Aboriginal') and CT is common in young people aged [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] years.(6-10) Prisoners, sex workers, and people who inject drugs (11) (12) (13) (14) (15) are also considered priority populations in national STI control strategies. (6) Testing and treatment is a key STI prevention and control strategy (16) and in Australia testing is recommended at least annually for most priority populations and more frequently for higher-risk GBM and sex workers. (17) (18) (19) STI testing is available at general practices, Aboriginal Community Controlled Health Services, sexual health clinics, family planning clinics and many other settings, with most STIs diagnosed via the primary care sector. (20) Most clinical services treat symptomatic patients immediately, however this only equates to a small proportions of infections. The vast majority of infections are asymptomatic (21) and involve clinicians sending specimens for laboratory testing with results typically available to the health service within a few days. However in some clinical settings, notably those in geographically isolated areas, significant delays occur between specimen collection and patient treatment due to a variety of reasons, often related to specimen transport and loss to follow up. Point-of-care (POC) testing has the potential to increase the number of people with STIs treated during the consultation and thereby reduce the duration of infectiousness.
Mathematical modelling indicates that POC testing could reduce STI prevalence in moderate 10.12.14 4 to high prevalence settings, especially where onward STI transmission is likely, due to long delays between testing and treatment and low return rates of patients for treatment. (22) POC tests for CT and NG have not been used widely in Australian or elsewhere due to suboptimal diagnostic accuracy. (23, 24) However recent technological advancements have led to the first molecular-based POC test for the dual detection of CT and NG.(25) The Xpert CT/NG assay (Cepheid) has sensitivity and specificity equivalent to the conventional laboratory-based nucleic acid amplification tests (NAAT) routinely used for STI diagnosis in Australia and elsewhere. (26, 27) In the context of the 'Test Treat ANd GO' (TTANGO) Trial, a randomised controlled trial of the Xpert CT/NG assay in remote Aboriginal communities, (28) we used qualitative methods to identify settings where CT/NG POC testing would be most clinically useful in Australia.
Methods

Ethics statement
Ethical approval for the study was received from the West Australian Aboriginal Health 
Study design
Between March and August 2013, in-depth interviews were conducted with key experts to explore, among other issues, potential settings where CT/NG POC testing may be beneficial 10.12.14 5 in Australia. The focus was on POC testing generally and not limited to NAAT, although NAAT were often the focus of discussion.
Participants
Purposive sampling was used to provide diversity in demographics and expertise. Participants (n=18) included sexual health physicians and nurses in urban, regional and remote health services (n=8), academics (n=2), policy makers (n=4), and laboratory based microbiologists (n=4). Participants were drawn from five of the eight Australian States and Territories, and included individuals with current or previous professional experience in remote Aboriginal communities. A number of participants had experience working with or in prison services and conducting outreach programs. The majority of participants were male (56%) and the average age was 49 years (range 39-58 years).
Interviews
Interviews were conducted by the first author in person where possible, or via telephone or internet, and lasted between 30 and 75 minutes. Written informed consent was obtained from all participants.
Data management and analysis
Recruitment continued until the data were saturated or no new themes emerged. (29) Interviews were digitally-recorded, transcribed verbatim and transcripts were later checked for accuracy against the recordings and to ensure familiarisation prior to analysis. Transcripts were uploaded into QSR Nvivo (Version 10), a qualitative data management and analysis program (QRS International PTY Ltd, Melbourne, Australia). Each transcript was systematically coded and content analysis was conducted to examine frequencies of recurring codes and to identify salient themes. (30)
Results
When considering the utility of CT/NG POC testing in Australia (Figure 1) 10.12.14 7 is that you treat them now rather than after they've had sex with two more people in the five days waiting for the result (Participant # 6).
There was consensus that CT/NG POC testing would be of greatest value in clinical settings that provide services to a high case load of young people, Aboriginal people, GBM, sex workers (specifically in the unregulated sex industry), and others who are highly transient or mobile and less likely to return for test results. These settings include:
Health services in rural and remote communities
Participants felt that POC testing would be especially suited to health services in rural and remote communities where prevalence of STIs is high. Some respondents suggested that testing might be provided through Aboriginal Community
Controlled Health services, government services, affiliated mobile women's clinics or small hospitals, and that it could be neatly integrated within the existing framework for adult health checks 1 .
Many highlighted the challenges of returning positive results to clients in remote communities and how resource-intensive this task can be in practice, suggesting that the timeliness of POC testing could make a positive difference.
[ 
Some participants noted that CT/NG POC testing might specifically appeal to young people in these communities, as they are often less likely to access health services and be more concerned about privacy and confidentiality.
[I]f a young person didn't want to be contacted afterwards, so they were worried about maybe having a visit or a phone call from the clinic and … 'outing' them as having a problem, being able to get their results at the same time and know they're not going to be contacted for results might be more acceptable to them (Participant # 12).
The possibility of providing molecular POC testing within rural/regional pathology services was also mentioned. Finally, some participants suggested that POC testing might be more suited to general practices in rural and regional centres where pathology turn-around time is slower, or in community health service settings not governed by a business model.
c) Prisons
Respondents held mixed views about the need and suitability of CT/NG POC testing within [
J]uvenile justice settings, very very quick turn-around, within 24 hrs ... and they have an unhealthily and frightening over-representation of young Aboriginal people … that would be an ideal setting to offer point-of-care testing (Participant # 3).
d) Outreach settings
Provided there are processes in place to offer treatment for positive clients, several respondents suggested that CT/NG POC testing might be utilised in a range of outreach settings, such as those provided by existing services (outreach mobile vans), or the largescale health screening initiatives in remote communities.
Country fairs, health community days, sporting events and music festivals were also mentioned as other community events that could be potential sites for opportunistic STI POC outreach testing.
[ One respondent emphasised the need for prevalence in the target population to be sufficiently high to justify outreach POC testing.
Outreach … services that deal with high risk populations. But it doesn't matter wherever it is, whether it's Arnhem Land or a footpath in Footscray where they look after drug users or sex workers … Doesn't matter, it's got to be a sufficiently high
prevalence to make it a cost-effective intervention (Participant # 6).
e) Other primary health care services
Other primary health care services identified as being potentially suited to CT/NG POC testing included sexual health clinics, hospital emergency departments, family planning services, youth-focussed services, student health services (e.g. within tertiary sector), and facilities that provide pap smear and antenatal care services, particularly in scenarios where non-medical staff may be available to perform the testing and provide the service at a cheaper cost than doctors.
Some felt that POC testing could be particularly useful in emergency departments, especially in hospitals that target women.
[ The potential to integrate CT/NG POC testing within needle and syringe programs was also mentioned, but only where services take a more comprehensive primary health care approach.
[I] wouldn't want to see it attached to any old needle and syringe program, but certainly the primary health care service model that exists in Victoria for people who inject drugs and other drug users ... like 'Inner Space' or 'Health Works' or 'The Foster
Street Clinic' down in Dandenong (Participant # 11).
Health services that reach sex workers in the unregulated sex industry, particularly migrant workers, were suggested as another potential site for POC testing.
[ Prisoners are recognised as a priority population for STI testing (11, 12) but testing coverage is often suboptimal. In a large audit of prison medical records in WA, CT and/or NG testing was documented for only 51% of prisoners.(11) For long stay prisoners, participants were unsure if POC testing would add value over laboratory based NAAT testing. (37) (38) (39) (40) Conversely a POC testing model may be more useful in juvenile detention centres where there is an over-representation of Aboriginal people, STI prevalence is high and there is a risk of loss to follow up due to short remand periods. In one study of STIs in a rural juvenile detention facility (41) the prevalence of urethral chlamydia was 16% among new mediumto-long-term detainees, the median age of participants was 17 years and 87% were
Aboriginal. In another study (11) it was found that among juveniles, females were significantly more likely to have a positive chlamydia test than males. Given the observed high prevalence of chlamydia among juvenile females and the difficulties involved in providing follow-up clinical management, juvenile females are now offered empirical treatment for chlamydia at the time of testing. If POC testing becomes available, empirical treatment may no longer be required. A formal assessment of the extent of loss to follow up and treatment delays in short-stay prisons is warranted to inform the potential for POC to be useful in this setting.
In surveys, the majority of GBM report a preference for HIV POC tests (rather than conventional laboratory tests) due to immediacy of result and convenience, (36, (42) (43) (44) (45) indicating CT/NG POC testing may be more acceptable than routine laboratory testing and subsequently achieve higher testing uptake and frequency. HIV POC testing for GBM has proven to be achievable and acceptable in a number of settings in Australia and overseas, (42, 43, 46) with Australian community-based services reaching a high proportion of GBM who have never previously been tested. (42, 43 ) Also for GBM with HIV infection, as HIV management checks are now being conducted less frequently, sometimes only yearly, then additional opportunities are needed for STI testing which is recommended every 3-6 months in high-risk men. In London, the Dean St sexual health clinic has recently introduced POC testing for CT/NG with reported success in reducing the time to treatment. (47) Our study has several limitations. The qualitative approach, small sample size and the nonrandom nature of the sampling strategy limit the generalisability of our findings. However, as we purposively sampled a broad range of recognised experts from different disciplines and jurisdictions with expertise in the testing and diagnosis of STIs, the volume of data generated was substantial, as was the depth and detail of the interview transcripts.
In conclusion, the stakeholders interviewed indicated a range of settings where POC testing may enhance the current approach to testing for CT and NG. However, as Australia has good laboratory infrastructure, there would need to be a comprehensive evaluation of improvements to treatment delays and loss to follow up for each population/setting where POCT is being considered, together with an assessment of POC test performance, cost, acceptability and public health impact. 
